Alliqua BioMedical Report issue

For profit Phase 2
Founded: Yardley PA United States (1997)
Status: Acquired by Adynxx, Inc. (2018)

Organization Overview

First Clinical Trial
2017
NCT03328676
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

TO Pharmaceuticals

Active Ingredients

Drugs in Phase 2 Trials (1)

cannabis (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dementia (Phase 2)

Hidradenitis (Phase 2)

Hidradenitis Suppurativa (Phase 2)

Marijuana Abuse (Phase 2)

Psychomotor Agitation (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1